Clinical Trial Update: Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the effectiveness and safety of an attenuated ATO plus low-dose ATRA regimen in patients with promyelocytic leukemia (APL), across P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Promyelocytic Leukemia

Drugs mentioned

• attenuated arsenic trioxide (ATO) plus low-dose all-trans retinoic acid (ATRA)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Promyelocytic Leukemia | Phase 1, Phase 2 | Status: UNKNOWN